SCHEMBL8094448

SCHEMBL8094448

c1ccc2ncc(SSc3cnc4ccccc4c3)cc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.57
PDGFRB P09619 3/20 0.50
PDGFRA P16234 3/20 0.50
MGAM O43451 1/20 0.50
ALDH1A1 P00352 4/20 0.48
MAPT P10636 2/20 0.48
HPGD P15428 2/20 0.48
GLA P06280 1/20 0.48
ACHE P22303 1/20 0.48
CYP2A6 P11509 1/20 0.47
BIRC5 O15392 1/20 0.46
KDM4E B2RXH2 1/20 0.45
GPR3 P46089 1/20 0.45
EGFR P00533 1/20 0.45
PIK3CD O00329 1/20 0.44
PIK3CA P42336 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
RAB9A P51151 2/20 0.43
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL271505 0.83 CYP1A2 (0.53) CYP1A2PDGFRBPDGFRAMGAMALDH1A1
SCHEMBL24593163 0.83 CYP1A2 (0.53) CYP1A2PDGFRBPDGFRAMGAMALDH1A1
SCHEMBL18814830 0.83 CYP1A2 (0.53) CYP1A2PDGFRBPDGFRAMGAMALDH1A1
SCHEMBL271506 0.83 CYP1A2 (0.59) CYP1A2PDGFRBPDGFRAMGAMALDH1A1
SCHEMBL30618060 0.81 HPGD (0.56) CYP1A2PDGFRBPDGFRAMGAMALDH1A1
SCHEMBL29105728 0.81 HPGD (0.56) CYP1A2PDGFRBPDGFRAMGAMALDH1A1
SCHEMBL455964 0.78 CYP1A2 (0.48) CYP1A2PDGFRBPDGFRAMGAMALDH1A1
SCHEMBL9620162 0.78 CYP1A2 (0.48) CYP1A2PDGFRBPDGFRAMGAMALDH1A1
SCHEMBL8569257 0.78 CYP1A2 (0.53) CYP1A2PDGFRBPDGFRAMGAMALDH1A1
SCHEMBL28028241 0.78 CYP1A2 (0.48) CYP1A2PDGFRBPDGFRAMGAMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6150375-A INHIBITORS OF BOTH OF THE HUMAN 5AR ISOZYMES; BENIGN PROSTATE HYPERPLASIA, MALE PATTERN BALDNESS, ACNE VULGARIS, SEBORRHEA, ANDROGENIC ALOPECIA, HIRSUTISM AND PROSTATE CANCER; BLOCKS THE CONVERSION OF TESTOSTERONE TO 5-ALPHA-DIHYDROTESTOSTERONE ELI LILLY AND COMPANY (US) 2000-11-21 US disclosed
US-5670514-A BENZOQUINOLIN-3-ONE ELI LILLY AND COMPANY (US) 1997-09-23 US disclosed
US-5635197-A BENZO(F)QUINOLIN-3-ONES; ANTICARCINOGENIC AGENTS; BONE DISORDERS ELI LILLY AND COMPANY (US) 1997-06-03 US disclosed
US-5629007-A USING BENZOQUINOLIN-3-ONE DERIVATIVES ELI LILLY AND COMPANY (US) 1997-05-13 US disclosed
US-5622961-A PROSTATE CANCER, SKIN DISORDERS, BALDNESS ELI LILLY AND COMPANY (US) 1997-04-22 US disclosed
US-5622962-A PROSTATE CANCER, SKIN DISORDERS, BALDNESS ELI LILLY AND COMPANY (US) 1997-04-22 US disclosed
US-5578724-A INHIBITORS OF 5-ALPHA-REDUCTASE ELI LILLY AND COMPANY (US) 1996-11-26 US disclosed
EP-0742010-A2 Benzoquinolin-3-ones to inhibit bone loss ELI LILLY AND COMPANY (US) 1996-11-13 EP disclosed
EP-0733365-A2 Use of benzoquinolin-3-ones for the treatment and prevention of prostatic cancer ELI LILLY AND COMPANY (US) 1996-09-25 EP disclosed
US-5550134-A ADMINISTERING TO A MAMMAL FROM A SERIES OF BENZOQUINOLIN-3-ONE COMPOUNDS ELI LILLY AND COMPANY (US) 1996-08-27 US disclosed